EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The regulatory frontier advancing cell and gene therapy policy in Singapore and beyond

Eddie Tan Han Pin

Cell and Gene Therapy Insights · 14.07.2026 · 12 (5) · 599–605

DOI: 10.18609/cgti.2026.073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell and Gene Therapy Insights, online erschienen am 14.07.2026. Verfasst von Eddie Tan Han Pin. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wil Rich, Editor, Cell & Gene Therapy Insights, speaks with Eddie Tan Han Pin, Assistant Professor, Centre of Regulatory Excellence, Duke‑NUS Medical School, about his career journey from molecular cancer biology through GMP manufacturing and regulatory science into health policy, the evolving regulatory landscape for cell and gene therapies in Singapore and the Asia‑Pacific region, the role of regulatory reliance frameworks in broadening equitable patient access, and the transformative potential of AI across the cell and gene therapy development value chain.

Zitieren

APA

Pin, E. T. H. (2026). The regulatory frontier advancing cell and gene therapy policy in Singapore and beyond. Cell and Gene Therapy Insights, 12(5), 599–605. https://doi.org/10.18609/cgti.2026.073

Vancouver

Pin ETH. The regulatory frontier advancing cell and gene therapy policy in Singapore and beyond. Cell and Gene Therapy Insights. 2026;12(5):599–605. doi:10.18609/cgti.2026.073

BibTeX
@article{Pin2026,
  author = {Pin, Eddie Tan Han},
  title = {The regulatory frontier advancing cell and gene therapy policy in Singapore and beyond},
  journal = {Cell and Gene Therapy Insights},
  year = {2026},
  volume = {12},
  number = {5},
  pages = {599–605},
  doi = {10.18609/cgti.2026.073}
}
Kostenlos starten →